0 participants
Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2022-08-03
- Start Date:
- 2020-11-23
- Completion:
- 2021-11-19
Conditions
- Asymptomatic COVID-19 Infection Laboratory-Confirmed
- B-Cell Neoplasm
- Chronic Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Mantle Cell Lymphoma
- Marginal Zone Lymphoma
- Small Lymphocytic Lymphoma
- Symptomatic COVID-19 Infection Laboratory-Confirmed
- Waldenstrom Macroglobulinemia
Interventions
- DRUG
- OTHER
No Results Yet